Log In
Print
BCIQ
Print
Print this Print this
 

GEN-003

  Manage Alerts
Collapse Summary General Information
Company Genocea Biosciences Inc.
DescriptionVaccine consisting of the infected cell polypeptide 4 (ICP4) and gD2 antigens from herpes simplex virus-2 (HSV-2) combined with the saponin-derivative adjuvant Matrix M
Molecular Target Infected cell polypeptide 4 (ICP4)
Mechanism of Action 
Latest Stage of DevelopmentPhase I/II
IndicationHerpes simplex virus (HSV)
Partner

Isconova AB
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today